OwningNovavax(NASDAQ:NVAX) in 2020 has been a fun ride. The biotech was trading hands for $4 a share at the beginning of 2020, and the price went as high as $189 in August. Currently, it's selling for about $85 a share.

What's behind these ups and downs (mostly ups)? Novavax is one of the biotechs that has declared war on the coronavirus. The drugmaker is a vaccine specialist, working to vaccinate the world and save us from this ugly disease. Let's see how you would have done if you had bought shares of Novavax during the market crash.

Image source: Getty Images.

If you bought this company in January (like I did), you likely did so for NanoFlu, its flu vaccine that was in the middle of phase 3 trials. In early January, nobody was talking about this strange new virus out in Wuhan. COVID-19 wasn't on our radar yet, and it was irrelevant to a buy decision then.

But of course, over time, COVID-19 became scarier and scarier, and vaccine stocks started shooting upward. On Friday, Jan. 17, Novavax's stock closed at $5.74 a share. Over the following weekend, Novavax announced that it was starting a program to find a vaccine for this new coronavirus. On Monday, the stock opened at $9.15 a share.

After a pullback at the end of January, Novavax quickly doubled in February, closing out the month at $16 a share. At this point, Novavax hadn't even found its vaccine candidate yet. Justthe fact that it was testing multiple vaccines in mice was enough to make people bullish.

As we headed into March, COVID-19 was dominating the news and the stock market. In my own portfolio, I would have days where all my stocks were bleeding out -- except for Novavax, which was green all the way. That's when the stock market bottomed out with peak negativity for the year. The lockdown was shutting down the world economy. It got so bad that even the vaccine drugmakers were sold off.

On March 16, shares of Novavax were trading for $7 a share, down more than 50% over just a couple of weeks. If you had the cash, March was a great time to buy stocks. With $10,000, you could have bought 1,400 shares of Novavax at $7.14 a share. You would have made a lot of money since.

Data provided by YCharts.

What caused Novavax to skyrocket so far and so fast? Unlike most of its competitors in the vaccine race, Novavax was (and remains) a company with a small market cap. In the spring, its valuation was under $1 billion. When you're that small, a blockbuster drug can really send your stock price soaring. And Novavax has two potential blockbusters in its pipeline. Its influenza vaccine, NanoFlu, has beaten the market-leading vaccines from Sanofiin multiple clinical trials, and when the company announced positive phase 3 data on March 24, Novavax's stock jumped up to $14 a share.

Of course, the stock market has really been focused on the company's COVID-19 vaccine, and the stock continued to fly high in April as investors tried to imagine how valuable this company might be. In May, the Coalition for Epidemic Preparedness (CEPI) gave Novavax a grant of $388 million to fund its COVID-19 vaccine research. This was followed by news on May 25 that Novavax had initiated human trials for its vaccine candidate, NVX-CoV2373. Now shares were worth $54.

In July, the world was shocked when Operation Warp Speed (the U.S. government program to fund vaccine candidates) paid $1.6 billion to relatively unknown Novavax in order to reserve 100 million doses of its COVID-19 vaccine candidate for possible future use. Then, on Aug. 4, Novavax announced positive phase 1 data from its clinical trial. The stock shot up to $189 a share on this news. That's when your $10,000 investment would have been worth a cool $264,600.

Of course, the stock has been cut in half since then, dropping down to $82 a share on Friday. Your Novavax investment is now worth about $114,800 -- still not a bad return.

Where will this stock go in the near term? Nobody knows. But the long-term outlook for Novavax is quite positive. Based on its phase 3 data, the company's flu vaccine, NanoFlu, is highly likely to be approved by the U.S. Food and Drug Administration (FDA). And so far, the COVID-19 data has many observers saying this vaccine is best-in-class. Here's hoping they are right.

Here is the original post:
If You Invested $10,000 in Novavax During the Coronavirus Market Crash, This Is How Much Money You'd Have Now - Motley Fool

COVID-19 may have the worlds attention, but Pfizer hasnt forgotten making investments elsewhere.

The New York pharma will invest 300 million ($350 million) to upgrade three Irish manufacturing sites in Grange Castle in Dublin, Newbridge in Kildare and Ringaskiddy in Cork, and add about 300 jobs over the next two to three years, the company said Monday.

The investments will be used to add new manufacturing capacity and lab space, as well as new technologies to ensure Pfizer is ready to support the next wave of medical innovations, it said.

Therapies requiring high volume injections are becoming more common across a broad range of therapeutic areas. This webinar will explore why adherence, safety and quality of life are important for patients, and how these key enablers contribute towards positive outcomes. We will also discuss existing challenges, such as drug development, regulatory, patient accessibility, and how device technologies can further improve patient outcomes. Register Today!

The three Irish sites manufacture drugs and vaccines in the areas of arthritis, inflammation, cancer, anti-infectives, hemophilia, pain and stroke, according to the company

The Ringaskiddy site, which wasPfizers first foothold in Ireland, will install adrug development operation to produce compounds for clinical trials. This is a very important development, as it expands Pfizers role in Ireland from the manufacture of already approved medicines into the support of an earlier phase of new medicine development, Paul Reid, Pfizer Irelands country manager said, as quoted by The Irish Times.

Pfizers currently in the spotlight for developing a COVID-19 vaccine with German partner BioNTech. The pairs mRNA candidate, BNT162b2, is among four programs currently in phase 3 efficacy trials in the U.S. Pfizer CEO Albert Bourla previously said the company could have preliminary efficacy data as early as October, but that didnt come through.

RELATED:Pfizer tags 3 U.S. manufacturing sites for possible COVID-19 vaccine launch

Right now, the firm doesnt intend to discuss any interim efficacy analysis until it has a conclusive readout from the data monitoring committee, Bourla told investors during a conference call last week. It will also accrue two-month safety data from half of the trial participants following the final dose of the vaccine, as the FDA requires. Based on our current trial enrollment and dosing pace, we estimate we will reach this milestone in the third week of November, he said.

In July, the company nabbed $1.95 billion from the U.S. government to supply 100 million doses of the vaccine upon emergency use authorization, with potentially an additional 500 million doses down the line. In the EU, where the BNT162b2 shot is under the European Medicines Agencys rolling review, Pfizer and BioNTech have penned an agreement to provide 200 million doses, with an option for 100 million more.

RELATED:Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024, endangering 470 positions

To make those shots, Pfizer has designated three U.S. sites and a Belgium facility as its COVID-19 vaccine manufacturing centers. The Grange Castle operation in Ireland is helping with quality testing batches for the Belgium plant, according to The Irish Times. Bourla has said the company will have relevant manufacturing data before the safety readout to support its COVID-19 application in the U.S.

The Irish investment comes as Pfizer isplanning to exita sterile injectables manufacturing site in Perth, Australia. The company intends to wind down operations there by 2023 and move its functions to its Melbourne, Australia, facility and other plants overseas.

Visit link:
Pfizer to invest 300M, add 300 jobs to expand 3 Irish manufacturing sites - FiercePharma

Dont miss these top money and investing features:

Election Day in the U.S. is almost here. These money and investing stories, popular with MarketWatch readers over the past week, offer advice and suggestions that can help you stay focused on your investments regardless of what happens in politics.

Americas in a betting mood ahead of the big event. The moment of truth for stock-market investors? Election Day looms and the most crucial stretch of 2020 awaits

Its not fixed income, but safer than equities and yielding close to 5% The asset class you probably havent even considered

More gambling goes on in the stock market than in all the worlds casinos combined. People are spending over three times more money gambling on hot stocks than at casinos and on lottery tickets and sports betting

Widespread investor pessimism is a contrarian indicator, writes Mark Hulbert. Most investors now expect the U.S. stock market to crash like it did in October 1987 why thats good news

Heres an introduction to how S&P 500 funds work, and whether one might be a good fit for your portfolio. What is the S&P 500 and how do I invest in it?

It's best to hold your own bonds managed by a professional. The high yields on municipal bonds are tempting, but you need to be mindful of these hidden risks

Look at cyclical stocks that pay dividends, not classic defensive picks. These are the 3 best dividend yield investments for 2021

For income investors, dividend reductions have been the unkindest cut of all. These dividend stocks have the potential to give you more money over time

High-quality shareholders and savvy CEOs have the same priority: effective capital allocation. Why companies that spend their capital wisely are smart places for your money

5G marketing is ubiquitous and the potential is huge. But when will consumers feel the impact? Whats ahead and when with Jeff McElfresh, the CEO of AT&T Communications. The potential for 5G Is huge, but when will consumers feel the impact?

James McDonald, CEO & CIO of Hercules Investments, delivers an ominous warning for investors about the health of U.S. equity markets. Dow 15,000?

U.S. stock market sectors from financials to energy will be affected by the election result - heres which ones could see the biggest changes. Which market sectors could be most affected by the election result

Read this article:
These money and investing tips can help you keep politics separate from your portfolio - MarketWatch

Top of mind for voters in 2020 is how to spark Americas economy as it struggles to rebound from COVID-19, yet the stakes go well beyond recovery. Our government faces a historic opportunity to rethink ways to promote prosperity for the long haul.

Bipartisan legislation recently introduced in Congress, calling for targeted government support of technology, holds tremendous promise for reversing a trend toward what is increasingly becoming a nation of haves and have nots.

For the past 50 years, the boom in U.S. technology has been most pronounced in so-called superstar cities on the coasts, places such as San Francisco, Seattle and Boston. Just five of the top innovation centers in the United States have generated a staggering 90 percent of innovation-sector growth.

The result has been soaring incomes and abundant jobs in those cities, while wide swaths of the country remain neglected, fueling income inequality. At the same time, people living in booming cities have suffered prohibitive living costs, declining quality of life, and social problems such as homelessness that have befuddled their politicians.

We have an opportunity to fix this.

The Brookings Institution has argued that a targeted federal effort could transform heartland metro areas into centers of economic expansion. Their economists concluded last year that government investment is needed to break the cycle where innovation-based companies tend to congregate near each other in pursuit of talent and hothouse thinking.

There is evidence that such bold acts can work. Seventy-five years ago, Vannevar Bush authored one of the most pivotal reports in U.S. history: Science The Endless Frontier. The policies based upon his call for investing in innovation propelled the United States to become the undisputed leader in many scientific fields. But recently, amid fierce global competition, we have started to lose this edge.

Inspired by this postwar victory, Sens. Chuck SchumerChuck SchumerHouse Democrats introduce bill to invest 0 billion in STEM research and education Graham dismisses criticism from Fox Business's Lou Dobbs Lewandowski: Trump 'wants to see every Republican reelected regardless of ... if they break with the president' MORE (D-N.Y.) and Todd YoungTodd Christopher YoungRepublicans: Supreme Court won't toss ObamaCare Vulnerable Republicans break with Trump on ObamaCare lawsuit Senate GOP eyes early exit MORE (R-Ind.), along with Reps. Ro KhannaRohit (Ro) KhannaHouse Democrats introduce bill to invest 0 billion in STEM research and education Biden says he opposes Supreme Court term limits Dozens of legal experts throw weight behind Supreme Court term limit bill MORE (D-Calif.) and Mike GallagherMichael (Mike) John GallagherActors union blasts Democrat for criticizing GOP lawmaker's wife Federal commission issues recommendations for securing critical tech against Chinese threats Government watchdog recommends creation of White House cyber director position MORE (R-Wis.), introduced the Endless Frontier Act in May, legislation to invest $100 billion in 10 tech opportunities. New investment in the most promising technological areas think artificial intelligence, quantum computing and advanced manufacturing has the potential to boost the American economy and promote key areas of national interest.

Critical to this approach will be ensuring that the benefits of federal investment are spread across the country, not just along the coasts, which is why the Endless Frontier Act includes money for 10 regional technology hubs. No place in the country offers a greater payoff for this type of government investment than the Badger Belt, a string of Wisconsin communities across a state filled with abundant natural resources, world-class universities, and hard-working families.

Wisconsin can be the centerpiece of a revitalized American heartland. We earned our nickname in the 19th century when pioneers were moving west. A few industrious souls burrowed into the Midwestern soil as miners, making Wisconsin their home and eventually turning the state into an innovative powerhouse. Todays Badgers are just as industrious and even more diverse.

Our initial focus begins with a segment of the Badger Belt anchored in Madison. Like the supercities, we have a powerhouse university that puts tremendous effort into transferring ideas into real-world technologies. We are a national leader in stem cell research and digital health technology. Madison also has a young, educated professional workforce and was identified by Moodys as one of the top 10 cities to weather the pandemic crisis.

The Brookings report last year called for 10 more Madisons, but we need all of Wisconsin to get this right. Most importantly, we are able to draw on the manufacturing heritage of communities along Lake Michigan, from Green Bay to Milwaukee to Kenosha, and the incredible potential such partnerships provide.

Progress on the Endless Frontiers Act has faltered, in part because of the pandemic-related turmoil and tight budgets of 2020. Congressmen Gallagher and Khanna continue to advocate for this legislation; they know reinvigorating this discussion must be a priority for the incoming Congress.

Political and industry leaders alike should endorse this bold first step toward broadening economic growth in the United States. This kind of targeting funding, when combined with other efforts such as workforce development, tax and regulatory benefits, business financing, and infrastructure support, could transform vital centers for economic growth.

The strength of American ingenuity once belonged to the American Midwest. With a smart technology policy from Washington, we are ready to take it back.

Erik Iverson is CEO of the nonprofit Wisconsin Alumni Research Foundation, which manages the transfer of technology and innovation coming out of the University of Wisconsin-Madison. The foundation would not directly benefit from the Endless Frontier Act, though the universitys researchers could be among those applying for grants.

The rest is here:
Reestablishing American prosperity by investing in the 'Badger Belt' | TheHill - The Hill

The New Construction Will Provide Housing, a Grocery and a Health Clinic

Governor Tom Wolf today announced that Commonwealth Cornerstone Group has completed a New Markets Tax Credit transaction of $16.5 million to help fund construction of a new shopping complex and 98 mixed-income units of rental housing along the 2000-2200 block of Ridge Avenue in North Philadelphia.

The 231,000-square-foot commercial shopping complex already has four major tenants lined up to begin business when construction is completed. They include a Grocery Outlet Market, an Everest Urgent Care/Adult Daycare center, a Santander Bank branch office, and a Wingstop restaurant. Some square footage remains for lease by other retailers. Three apartment buildings will be constructed as part of the mixed-use center offering mixed-income housing, including 17 units at 60 percent of area median income and an additional 13 units at 80 percent of area median income.

The mix of commercial and residential tenants, paired with the improved streetscape, is part of a revitalization effort led by the Philadelphia Housing Authority to reinvigorate the Sharswood neighborhood in North Philadelphia that has seen years of disinvestment.

This new development can help revitalize the Sharswood-Blumberg area of north Philadelphia, said Gov. Wolf. The investment of New Markets Tax Credits in this mixed-use development is a good first step to bring positive change.

Mosaic Development Partners and Shift Capital, two local community impact developers, led the effort along with the Philadelphia Housing Authority, which has been heavily involved in this development and has identified it as a community anchor in the Sharswood/Blumberg Neighborhood Transformation Plan. According to the plan, the economic revitalization of the Ridge Avenue corridor will provide basic amenities like a grocery store and a health care clinic to improve the quality of life there. That part of North Philadelphia currently is described as a food desert and a medically underserved area.

Investment is sorely needed to bring improvements in that part of North Philadelphia, said PHFA Executive Director and CEO Robin Wiessmann. The goal of Commonwealth Cornerstone Group is for these tax credits to bring a project to fruition that has tremendous potential to start positive momentum in the Sharswood-Blumberg area.

This project is expected to create 109 temporary, full-time construction jobs. Following construction, all the employers at the site will create 100 full-time equivalent jobs. The weighted average wage for all tenants is anticipated to be $13.40/hour. The MIT living wage for Philadelphia County is $12.64/hour. According to economic estimates, the projects construction costs will support 27 indirect jobs, and the businesses located at the site will support 28 indirect jobs.

This development is consequential to the revitalization of the Sharswood/Blumberg community, said Greg Reaves, principal, Mosaic Development Partners. Our team is thrilled to have Commonwealth Cornerstone Group make such a significant commitment, along with the other tax credit and private investors, to bring these essential services and high-quality housing to a community in need.

The goal of CCG, through its administration of New Markets Tax Credits, is to fund projects in key areas of communities that have historic or cultural value and offer opportunities to spark economic revitalization. CCG utilizes NMTCs to provide loans and equity investments for business expansion, mixed-use development, and community facilities across Pennsylvania. Examples of past developments that have benefited from CCGs investment of tax credits include Mill 19 at Almono in Pittsburgh, the Susquehanna Health Innovation Center in Williamsport and Eastern Tower in Philadelphia. Learn more at: commonwealthcornerstone.org.

The New Markets Tax Credit Program was established by Congress in 2000 to spur new or increased investments in operating businesses and real estate projects located in low-income communities. The NMTC Program attracts investment capital to low-income communities by permitting individual and corporate investors to receive a tax credit against their federal income tax return in exchange for making equity investments in specialized financial institutions called community development entities, such as Commonwealth Cornerstone Group. The program is administered by the U.S. Department of the Treasury.

Follow this link:
Gov. Wolf Announces Investment of Tax Credits in North Philadelphia to Build Development - pa.gov

OLYMPIA, WA - Gov. Jay Inslee today announced the allocation of $24 million in Coronavirus Relief Funds to purchase approximately 64,000 computing devices for students across the state.

These devices will enable students to receive their education in the new COVID-19 remote learning environment. The first shipment of 20,000 devices is expected in the coming weeks.

Having their own device is vital to students and staff participating and succeeding in distance learning, Inslee said. The COVID-19 pandemic has thrown challenges at every Washingtonian, especially working families and students having the proper equipment to navigate their new educational reality shouldnt be one of those challenges.

At the beginning of the 20202021 school year, more than 95% of students in Washington began the year in remote learning due to the COVID-19 pandemic. However, according to the Office of the Superintendent of Public Instruction (OSPI) and the nine regional educational service districts, approximately 64,000 students and school staff statewide do not currently have their own computing device or tablet.

Due to the impacts of COVID-19, the current manufacturing and global supply chain for computing devices is limited. Many districts that have devices on order have had their delivery dates pushed to six weeks, three months or more. And some districts just simply dont have enough CARES Act or local funding to make all the purchases necessary. Bulk procurement on the part of the state will help to bring devices to Washington more quickly and at a lower rate.

Devices must meet the needs of students and local districts, provide adequate technical specifications, and be available in the near-term at a competitive price. Due to the source of funding, devices must be received before the end of the year.

With most of our students learning from home right now, one critical need has been access to technology, said Superintendent of Public Instruction Chris Reykdal. Since last spring, school districts across the state have deployed hundreds of thousands of laptops and tablets to students so they can learn remotely. Im grateful to the governors office for their partnership as we continue to close the digital divide.

While having a device is necessary to participate in distance learning, connectivity to the internet also poses a barrier to participating in remote learning. To help meet this need, OSPI has allocated $8.8 million in CARES Act funds to buy internet plans for 60,000 families who cannot afford them. In addition, the state has set up more than 600 WIFI hotspots across Washington, with the governor reviewing proposals to further speed up the state path to universal broadband connection.

The governor, along with Educational Service Districts and OSPI, will work to identify which districts will receive the first shipment of devices in early November.

Read this article:
Inslee announces technology investment for Washington students and staff - NBC Right Now

The potential of 5G is already on the radar of investors around the world, with revenue from 5G wireless network infrastructure expected to reach $8.1 billion in 2020. That represents a 96% increase from 2019, according to Gartner, a research firm.

As COVID-19 continues its destructive path, many countries and regions around the world see 5G expansion as a pathway to economic recovery and growth. As a result, governments, private industry and investors are lining up to make the necessary investments to advance the infrastructure needed for 5G.

What was once seen as a longer-term play, 5G is blossoming in a period when it is needed most. So-called pioneer countries, including the United States, Japan, South Korea and China have already deployed the first high-band 5G networks in select major cities, according to a 2020 McKinsey report. Meanwhile, Apple recently unveiled its inaugural 5G phone lineup.

For these reasons, we believe the time is now to take advantage of this growing yet underappreciated trend. Across its supply chain, 5G is poised to make a significant impact, from the infrastructure powering the network to the equipment and retail service providers evolving their product suites to leverage its enhanced capabilities.

As the momentum around 5G grows, here are several ways investors can take advantage now:

Much of the current investment interest in 5G is centered on cellular communications towers. These macro towers remain the most cost-effective way to deploy wireless spectrum and they are in short supply in many areas.

In the U.S., there are about 150,000 towers, around 95% of which are owned by private operators. In Europe, there are about 350,000 towers and just 20% are privately owned. The number of towers in Europe is expected to grow to 450,000 sites by 2025, according to Morgan Stanley. Many countries, however, are starting with a much lower base. Mexico has just 33,000 while Brazil has only 61,000, according to JP Morgan research estimates.

We believe cell towers are the most attractive pure play to take advantage of 5G. For one, 5G requires more towers to operate effectively, and given the cost and complexity of siting, building and upgrading towers and other infrastructure, the barriers to entry are high. Once that infrastructure is in place, however, operating costs are relatively low, and the towers have a long operational life. We also appreciate the potential resilience of communications infrastructure given its presumed lower correlation and volatility compared with some other asset classes.

Most private cell-tower operators are traded on the stock market, and there are different ways to invest them. If youre looking for more mature, U.S.-based firms, Crown Castle International CCI, -0.95% and American Tower AMT, -0.86% generate strong dividends and stable growth, with American Tower also providing international exposure.

For a higher growth play, Spain-headquartered Cellnex Telecom CLNX, +3.02% continues to buy and consolidate tower portfolios in Europe, including recent acquisitions in Poland. Cellnex has consistently outperformed the stock market over the past two years, and given the opportunity for privatization in Europe, theres still room for growth.

Moving past cell tower companies and further down the supply chain, equipment operators and manufacturers are also poised to take advantage of the 5G boom. Semiconductors will be an integral part of the transition to 5G, and firms such as Broadcom AVGO, -1.51% and Samsung Electronics 005930, -2.58% that create chips for cell phones and other mobile devices stand to benefit as leading players in the space.

In addition to improving mobile and remote capabilities, offices, apartment buildings and public utilities such as airports and mass transit will be built and/or renovated with the latest 5G capabilities. Equipment suppliers such as Nokia NOK, +0.59% NOKIA, +3.20%, which has a strong foothold in the space, should expand its market share.

Among the largest beneficiaries of the 5G evolution will be the service providers and device manufacturers that power and create the technologies we as consumers use every day. In recent years, consumers have been less motivated to buy the latest phone models because of their high prices and limited advancements, but new models with 5G compatibility will provide companies such as Apple AAPL, -5.60% and Samsung Electronics two of the worlds largest cell phone manufacturers ample reason to entice existing customers into upgrading their devices.

At the same time, consumers will be inclined to purchase higher-priced data plans that incorporate 5G. Were already seeing this trend in Asia, where service providers have increased their average revenue per unit by 30% for high-data 5G plans.

In the U.S., the big three U.S. providers Verizon VZ, +0.40%, T-Mobile TMUS, +0.05% and AT&T T, +0.97% are racing to secure the fastest and most reliable networks.

We think T-Mobile is the most attractively valued and in the best position to gain market share. Following its merger with Sprint, T-Mobile has a vast wireless spectrum and is poised to have a strong 5G network.

Now read: Here are five stocks to own for the 5G network buildout

Josh Duitz is a senior portfolio manager at Aberdeen Standard Investments and the co-manager of the Aberdeen Standard Global Infrastructure Income Fund ASGI, -1.73%. Across his funds, he holds shares in Apple, Crown Castle International, Cellnex Telecom, American Tower, Broadcom, Samsung Electronics, Nokia and T-Mobile.

View post:
The best 5G pure-play investment is in cellphone-tower operators - MarketWatch

Etsy is doubling down on its marketing campaign as the online store looks to retain the customers it gained during the pandemic.

CEO Josh Silverman told CNBC's Jim Cramer on Thursday he is pleased with the returns he's seen from its marketing spending in recent years and that the company is dialed in to continue the strategic investments.

"We're going to keep being super disciplined about our investment," he said in a "Mad Money" interview. "This is a moment when Etsy is really top of mind for millions of consumers and it's the perfect moment for Etsy to be leaning in and really investing in marketing."

The comments came one day after the online platform, which specializes in selling handmadeand personalized items, topped Wall Streets' estimates in its third-quarter report. Despite bringing in $451 million in revenue, more than double from the year-ago quarter, the stock sold off 5% in Thursday's session.

Etsy tallied $127 million in marketing expenses in the July-to-September quarter, which made up a large part of its roughly 86% year-over-year increase in operating expenses, and the e-retailer plans to continue spending big on its strategy in the current quarter. The company is expecting a lower return on investment, however, and says it will impact margins.

Etsy has focused on television, digital and performance marketing, the company said.

Silverman pointed out that Etsy, which was added to the S&P 500 in September, is now mentioned alongside other big players in the e-commerce space like Amazon, Walmart and Target. At $132.42 per share at Thursday's close, the market values the company at $15.8 billion.

"We're suddenly in the same breath as brands that are 50 or 100 times bigger than Etsy, and we have the potential to be so much bigger than we are today," he said. "It's just being about top of mind."

Etsy's gross merchandise value, which retailers use to measure growth, was up 119% to $2.6 billion in the third quarter, the company said. The company grew revenue by 128% during the period to $451 million and produced 70 cents in earnings per share, beating estimates by 10 cents per share.

The stock is up nearly 200% year to date.

Read more from the original source:
Etsy CEO calls this is the 'perfect moment' to invest in marketing - CNBC

DUBLIN, Oct. 30, 2020 /PRNewswire/ -- The "United States Plant Protein Business and Investment Opportunities (2018-2027) Insight Series - White Space/Gap Analysis, Product Strategy, Innovation and Brand Share Analysis, Competitive Landscape, Market Size Across 50+ Segments - Updated in Q3, 2020" report has been added to ResearchAndMarkets.com's offering.

The plant protein market in United States is estimated to record a steady growth with a CAGR of 19.6% during 2018-2020. Plant protein industry is expected to continue to grow in United States over the forecast period and is expected to record a CAGR of 17.3% during 2021-2027. The plant protein consumption in the country will increase from US$ 4706.2 million in 2019 to reach US$ 17326.9 million by 2027.

The US food industry has noticed a paramount shift when it comes to the adoption of plant-based proteins in the last decade. Poultry and beef protein consumption still holds the majority percentage in the country. However, consumers particularly, the millennials and Gen Z population are leaning towards plant-based protein products. Future growth prospect of the market is attracting startups to participate in the market. It is expected that innovative products using new ingredients will drive the future growth of the market.

Moreover, COVID-19 has reinforced the demand for plant-based products especially, plant-based meats, thereby inducing competition in the market. The sector has recorded a significant increase in the number of new product launches. Similarly, the number of food tech companies is increasing and expected to increase rivalry in the market in the short term.

Scope

This research report provides in-depth analysis of plant protein industry in United States, providing white space/gap analysis, product innovation, product claims analysis, and brand share analysis, competitive landscape, market size across 50+ segments. Below is the taxonomy, providing detailed scope of coverage.

United States Plant Protein Market Dynamics - Strategy & Innovation

United States Plant Protein Market Size by Ingredients

United States Plant Protein Market Size by Product Categories

United States Plant Protein Market Size by Functional Segments

United States Plant Protein Market Share Analysis by Sales Channels

United States Plant Protein Market Share Analysis by Type of Retail Outlet

United States Plant Protein Market Size by Retail Sales Pricing

United States Plant Protein Market Size by Cities

United States Plant Protein Consumption by Demographics

Reasons to Buy

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/dfe2zy

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

View post:
United States Plant Protein Market and Investment Opportunities Report 2020: Consumption in the Country will Increase from US$ 4706.2 Million in 2019...

A commentary published last week in The Salt Lake Tribune advocated for Utahs return to the ill-advised war on drugs approach to low-level crime which wasted a fortune in incarceration costs and ruined countless lives. The commentary by U.S. Attorney John W. Huber attacked Utahs innovative Justice Reinvestment Initiative and made dubious claims supported neither by data nor research.

JRI was passed by the Utah Legislature in 2014 with a phased implementation beginning in 2015 and 2016. The goal of JRI is to keep low-level offenders from clogging up our jails and prisons; get them into behavioral treatment for mental illness and/or addiction disorders; provide enhanced supervision to ensure compliance to treatment regimens and to keep Utah communities safe. The net effect moves limited public funds from the back-end approach of incarceration to the front-end approach of treatment.

Research supports justice reform. The Vera Institute of Justice as well as the Pew Charitable Trust have both reported that states that have adopted more thoughtful criminal justice policies have reduced their incarceration rates and their crime rates.

The Pew Charitable Trust also evaluated Utahs planned JRI approach and found the states criminal-justice reform law successfully kept people out of expensive prison cells who dont represent a threat to public safety. Reforms also reduces the number of individuals tagged with felony convictions that create a significant barrier to future employment opportunities, housing and self-sufficiency.

Since its phased implementation beginning in 2015, several significant challenges have faced the full implementation of the JRI. With its passage came revised sentencing criteria that allowed prosecutors and judges to divert drug offenders into community-based residential programs.

While the Legislature did provide funding, it was nowhere near the amount necessary to build up the treatment capacity necessary to serve those who were now being diverted from incarceration. Additionally, the implementation coincided with the opioid crisis which increased the number of persons needing addiction treatment alternatives in an already stressed treatment capacity system.

Consequently, low-level drug offenders who were then being released under new sentencing criteria did not have treatment beds available in which to be placed, and were more likely to, once again, be arrested, jailed, and sent through the court system.

The major challenge facing the implementation of the JRI was one of adequate funding. Finally, in 2017, the Legislature passed the Targeted Adult Medicaid (TAM) program sponsored by Rep. James Dunnigan. The legislation included a federal waiver request to allow for the expansion of residential treatment capacity within existing treatment centers statewide. With the federal governments approval of TAM and the waiver request to increase capacity, Medicaid funds could now be used to increase treatment capacity to the level necessary to fully implement the goals of JRI. This legislation was a major game changer.

In 2017, there were 170 residential addiction treatment beds within Salt Lake County. At the beginning of 2019, there were 550. And now with the full Medicaid expansion in Utah, we are very close to eliminating the treatment capacity gap altogether.

So, is JRI working? We believe it will now, so Iet us take a deep breath and allow JRI do what it was designed to do.

Finally, we must address the question of behavioral health disorders (mental illnesses and addictions) and how they should be dealt with in Utah and within the United States. Behavioral health disorders are health problems, not criminal justice problems. In the past, due to a lack of affordable treatment for most Utahns dealing with behavioral health problems, it has fallen on our courts and law enforcement systems to deal with those behavioral health disorders. This is a waste of precious resources.

It is time to integrate behavioral health treatment into our primary health care system. This will allow earlier preventive care, intervention and early treatment to take place just as it does with any other disease it is time to treat behavioral health disease like any other disease and not as a crime.

In the long run, earlier access to health care is the right thing to do and it saves lives, families and the Utah taxpayer.

Jim Bradley is an at-large member of the Salt Lake County Council.

Patrick Fleming is chair of the Utah State Substance Use and Mental Health Advisory Council.

Link:
Jim Bradley and Patrick Fleming: Put 'investment' into Justice Reinvestment Initiative - Salt Lake Tribune